Valuation: SOPHiA GENETICS SA

Market Cap 46Cr 40Cr 37Cr 35Cr 65Cr 4.41TCr 67Cr 446.59Cr 175.06Cr 2.17TCr 173.54Cr 169.78Cr 7.51TCr P/E 2026 *
-6.07x
P/E 2027 * -7.93x
Enterprise Value 46Cr 40Cr 37Cr 35Cr 65Cr 4.41TCr 67Cr 446.59Cr 175.06Cr 2.17TCr 173.54Cr 169.78Cr 7.51TCr EV / Sales 2026 *
4.95x
EV / Sales 2027 * 4.11x
Free-Float
76.74%
Yield 2026 *
-
Yield 2027 * -
1 day+4.77%
1 week+9.31%
Current month+1.41%
1 month+9.78%
3 months+26.25%
6 months+12.72%
Current year+30.15%
1 week 4.56
Extreme 4.56
5.05
1 month 4.18
Extreme 4.18
5.2
Current year 3.46
Extreme 3.46
5.2
1 year 3.34
Extreme 3.34
5.2
3 years 2.08
Extreme 2.08
5.2
5 years 2.08
Extreme 2.08
5.2
10 years 2.08
Extreme 2.08
5.2
Manager TitleAgeSince
Chief Executive Officer 46 01/07/2026
Director of Finance/CFO 64 05/11/2024
Chief Tech/Sci/R&D Officer - 10/01/2022
Director TitleAgeSince
Chairman 47 22/06/2026
Director/Board Member 57 01/06/2014
Chairman 61 01/02/2020
Change 5-day change 1-year change 3-year change Capi.($)
+4.77%+9.31% - - 46Cr
+1.51%-1.93%-33.53%-5.41% 3.06TCr
-0.81%+3.72%-33.03%+234.32% 1.53TCr
+1.07%-3.33%-21.29%+63.38% 557.34Cr
+5.70%-1.45% - - 225.52Cr
-1.26%-9.85% - - 203.44Cr
+1.84%+6.04%+52.40%-36.92% 205.2Cr
+0.85%-16.95%-30.60% - 109.4Cr
-1.15%+5.85%+54.34%+128.10% 103.11Cr
+2.11%-0.26%-34.11%+303.82% 80Cr
Average +1.37%-1.51%-6.54%+114.55% 674.75Cr
Weighted average by Cap. +0.91%+1.46%-27.41%+73.67%

Financials

2026 *2027 *
Net sales 9.34Cr 8.17Cr 7.53Cr 6.97Cr 13Cr 891.53Cr 13Cr 90Cr 35Cr 437.8Cr 35Cr 34Cr 1.52TCr 11Cr 9.83Cr 9.07Cr 8.39Cr 16Cr 1.07TCr 16Cr 108.56Cr 43Cr 526.74Cr 42Cr 41Cr 1.82TCr
Net income -6.46Cr -5.66Cr -5.22Cr -4.83Cr -9.16Cr -617.09Cr -9.31Cr -62Cr -24Cr -303.03Cr -24Cr -24Cr -1.05TCr -5.07Cr -4.44Cr -4.09Cr -3.79Cr -7.19Cr -484.17Cr -7.31Cr -49Cr -19Cr -237.76Cr -19Cr -19Cr -823.56Cr
Net Debt - -
Logo SOPHiA GENETICS SA
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
Employees
415
Date Price Change
10/26/10 5.050 +4.77%
08/26/08 €4.820 +1.69%
07/26/07 €4.740 +1.72%
06/26/06 €4.660 +0.87%
03/26/03 €4.620 0.00%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.510USD
Average target price
8.000USD
Spread / Average Target
+45.19%

Quarterly revenue - Rate of surprise